ArticleOncogene2020
SHP2 is a multifunctional therapeutic target in drug resistant metastatic breast cancer.
Hao Chen et al.PubMed ↗Full text ↗Publisher ↗
No numbers read from the abstract.
37 papers cite it
this papercites it
ArticleOncogene2020
Hao Chen et al.PubMed ↗Full text ↗Publisher ↗
No numbers read from the abstract.